Overview of Dr. Adusumilli
Dr. Prasad Adusumilli is a thoracic surgeon in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Guntur Medical College NTR and has been in practice 31 years. Dr. Adusumilli accepts several types of health insurance, listed below. He is one of 39 doctors at Memorial Sloan Kettering Cancer Center who specialize in Thoracic Surgery. He has more than 100 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Education & Training
- UPMC Medical EducationFellowship, Thoracic Surgery, 2005 - 2007
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Surgery, 1999 - 2002
- Maimonides Medical CenterResidency, Surgery, 1995 - 1998
- Guntur Medical College NTRClass of 1989
Certifications & Licensure
- FL State Medical License 2024 - Present
- NY State Medical License 2007 - 2026
- NJ State Medical License 2019 - 2025
- CT State Medical License 2000 - 2007
- PA State Medical License 2005 - 2007
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC) Start of enrollment: 2011 Mar 01
- T-Cell Therapy for Advanced Breast Cancer Start of enrollment: 2016 Jun 01
- A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma Start of enrollment: 2023 Aug 04
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 162 citationsSolid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Post...Hideki Ujiie, Kyuichi Kadota, Jamie E. Chaft, Daniel Buitrago, Camelia S. Sima
Journal of Clinical Oncology. 2015-08-10 - 189 citationsInitial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancerMatthew J. Bott, Stephen C. Yang, Bernard J. Park, Prasad S. Adusumilli, Valerie W. Rusch
The Journal of Thoracic and Cardiovascular Surgery. 2019-07-01 - 35 citationsVisceral Pleural Invasion Does Not Affect Recurrence or Overall Survival Among Patients With Lung Adenocarcinoma ≤ 2 cm: A Proposal to Reclassify T1 Lung AdenocarcinomaJun-ichi Nitadori, Christos Colovos, Kyuichi Kadota, Camelia S. Sima, Inderpal S. Sarkaria
Chest. 2013-11-01
Journal Articles
- A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung AdenocarcinomaMatthew J Bott, Daniela Molena, Prasad S Adusumilli, JAMA Surgery
Press Mentions
- Prasad S. Adusumilli, MD, FACSFebruary 27th, 2024
- Getting a Second Opinion After a Cancer Diagnosis: 9 Things to KnowMay 4th, 2023
- Researchers in Japan Study Inhalable Gene Therapy for MesotheliomaJuly 12th, 2022
- Join now to see all
Professional Memberships
- Member
- Fleischner SocietyMember
- American Surgical AsociationMember
- American Society of Clinical InvestigationMember
- American Society of Thoracic SurgeryMember
Insurance Accepted
- BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Multiplan PHCS PPOMultiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: